Soluble neprilysin and survival in critically ill patients

Soluble neprilysin and survival in critically ill patients

Abstract Background Critically ill patients admitted to an intensive care unit (ICU) exhibit a high mortality rate irrespective of the initial cause of hospitalization. Neprilysin, a neutral endopeptidase degrading an array of vasoactive peptides became a drug target within the treatment of heart fa...

Full description

Bibliographic Details
Main Authors: Max Lenz, Konstantin A. Krychtiuk, Mira Brekalo, Dominik F. Draxler, Noemi Pavo, Christian Hengstenberg, Kurt Huber, Martin Hülsmann, Gottfried Heinz, Johann Wojta, Walter S. Speidl
Format: Article
Language:English
Published: Wiley 2022-04-01
Series:ESC Heart Failure
Subjects:
Neprilysin
Soluble neprilysin
Critical care
ICU
30 day mortality
Online Access:https://doi.org/10.1002/ehf2.13787

Internet

https://doi.org/10.1002/ehf2.13787

Similar Items